Sector consensus GSK plc

Equities

Market Closed - London S.E. Other stock markets 19:35:26 08/05/2026 +04			5-day change	1st Jan Change
1,843.00 ^GBX	-0.83%		-3.05%	+1.01%

05-07	Halozyme, GSK Enter Collaboration, Licensing Agreement	MT
05-07	Halozyme announces global collaboration and license agreement with GSK to develop subcutaneous formulations of multiple promising oncology targets	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
GSK PLC	20.3	+10.15%	20
ELI LILLY AND COMPANY	1,209.14	+27.49%	29
JOHNSON & JOHNSON	252.42	+14.05%	24
ABBVIE INC.	252.23	+25.15%	30
ROCHE HOLDING AG	360.76	+14.42%	17
ASTRAZENECA PLC	221.63	+21.89%	21
NOVARTIS AG	155.32	+6.53%	21
MERCK & CO., INC.	129.74	+16.48%	27
NOVO NORDISK A/S	307.34	+5.87%	23
AMGEN INC.	353.07	+6.44%	30
GILEAD SCIENCES, INC.	158.07	+20.36%	28
PFIZER INC.	29.11	+13.37%	27
BRISTOL-MYERS SQUIBB COMPANY	63.32	+12.75%	25
VERTEX PHARMACEUTICALS INCORPORATED	549.5	+27.84%	28
SANOFI	97.1	+32.83%	23
CHUGAI PHARMACEUTICAL CO., LTD.	10,096.67	+27.81%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	6,036.87	+15.8%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	80.38	+52.24%	17
BAYER AG	48.47	+31.08%	19
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	40.27	+12.71%	11
Average	1,023.09	+19.76%	22
Weighted average by Cap.	677.81	+18.93%	25